EVALUATION OF THE EFFECT OF JAMBEERA PINDA SWEDA IN CERVICAL SPONDYLOSIS WRT CLINICAL SYMPTOMATOLOGY

CCRAS0 个研究点目标入组 59 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Cervical Spondylosis with clinical and radiological evidence of Cervical Spondylosis with or without cervical radiculopathy.
•2.Willing Patients with informed consent obtained.

•1. Age below 30 years and above 65 years.
•2. Cases of cervical Spondylosis with intractable pain, neurological deficit, severe deltoid or wrist extensors weakness.
•3. Patients with any cervical pathology apart from Cervical Spondylosis excluding any clinical evidence of Cervical Spondylotic myelopathy.
•4. Patients with poorly controlled Hypertension ( 140/90 mmHg).
•5. Patients with poorly controlled Diabetes Mellitus having HbA1C of 7.5%
•6. Patients who have a past history of any type of heart disease or stoke.
•7. Patients with any hepatic or renal disorder, with liver enzymes twice the normal or S. creatinine 1.4 mgm.
•8. Any other condition which the Investigator thinks may jeopardize the study.

发起方

CCRAS